Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Thoracic Surgery

  Free Subscription


Articles published in Am Heart J

Retrieve available abstracts of 63 articles:
HTML format
Text format



Single Articles


    March 2017
  1. LEE H, Koo BK, Park KW, Shin ES, et al
    A randomized clinical trial comparing long-term clopidogrel vs aspirin monotherapy beyond dual antiplatelet therapy after drug-eluting coronary stent implantation: Design and rationale of the Harmonizing Optimal Strategy for Treatment of coronary arte
    Am Heart J. 2017;185:17-25.
    PubMed     Text format     Abstract available


    January 2017
  2. RIMAC G, Fearon WF, De Bruyne B, Ikeno F, et al
    Clinical value of post-percutaneous coronary intervention fractional flow reserve value: A systematic review and meta-analysis.
    Am Heart J. 2017;183:1-9.
    PubMed     Text format     Abstract available


    December 2016
  3. MEHTA RH, Van Diepen S, Meza J, Bokesch P, et al
    Levosimendan in patients with left ventricular systolic dysfunction undergoing cardiac surgery on cardiopulmonary bypass: Rationale and study design of the Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery
    Am Heart J. 2016;182:62-71.
    PubMed     Text format     Abstract available


  4. BABER U, Dangas G, Cohen DJ, Gibson CM, et al
    Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study.
    Am Heart J. 2016;182:125-134.
    PubMed     Text format     Abstract available


  5. GRODZINSKY A, Arnold SV, Wang TY, Sharma P, et al
    Bleeding risk following percutaneous coronary intervention in patients with diabetes prescribed dual anti-platelet therapy.
    Am Heart J. 2016;182:111-118.
    PubMed     Text format     Abstract available


  6. LEE JM, Cho DK, Hahn JY, Song YB, et al
    Safety of 6-month duration of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndromes: Rationale and design of the Smart Angioplasty Research Team-safety of 6-month duration of Dual Antiplatelet The
    Am Heart J. 2016;182:1-8.
    PubMed     Text format     Abstract available


    November 2016
  7. YAKSH A, Kik C, Knops P, van Ettinger MJ, et al
    Early, de novo atrial fibrillation after coronary artery bypass grafting: Facts and features.
    Am Heart J. 2016;184:62-70.
    PubMed     Text format     Abstract available


  8. PICCARO DE OLIVEIRA P, Gonzales V, Lopes RD, Schmidt MM, et al
    Serious infections among unselected patients with ST-elevation myocardial infarction treated with contemporary primary percutaneous coronary intervention.
    Am Heart J. 2016;181:52-59.
    PubMed     Text format     Abstract available


  9. DERY JP, Mehta SR, Fisher HN, Zhang X, et al
    Baseline characteristics, adenosine diphosphate receptor inhibitor treatment patterns, and in-hospital outcomes of myocardial infarction patients undergoing percutaneous coronary intervention in the prospective Canadian Observational AntiPlatelet sTud
    Am Heart J. 2016;181:26-34.
    PubMed     Text format     Abstract available


    October 2016
  10. SRA S, Tan MK, Mehta SR, Fisher HN, et al
    Ischemic and bleeding events in patients with myocardial infarction undergoing percutaneous coronary intervention who require oral anticoagulation: Insights from the Canadian observational AntiPlatelet sTudy.
    Am Heart J. 2016;180:82-9.
    PubMed     Text format     Abstract available


    September 2016
  11. MCNEELY C, Markwell S, Vassileva CM
    Readmission after inpatient percutaneous coronary intervention in the Medicare population from 2000 to 2012.
    Am Heart J. 2016;179:195-203.
    PubMed     Text format     Abstract available


  12. TANGUTURI VK, Wasfy JH
    Hospital readmissions after percutaneous coronary intervention aredeclining, but caution ahead is needed.
    Am Heart J. 2016;179:192-4.
    PubMed     Text format    


  13. DE WAHA A, Sandner S, von Scheidt M, Boening A, et al
    A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial: An Inve
    Am Heart J. 2016;179:69-76.
    PubMed     Text format     Abstract available


    August 2016
  14. DECKER C, Garavalia L, Garavalia B, Gialde E, et al
    Understanding physician-level barriers to the use of individualized risk estimates in percutaneous coronary intervention.
    Am Heart J. 2016;178:190-7.
    PubMed     Text format     Abstract available


  15. ROTHBERG MB, Martinez KA
    Risky business: Personalizing the approach to percutaneous coronary intervention.
    Am Heart J. 2016;178:185-7.
    PubMed     Text format    


  16. TABBALAT RA, Hamad NM, Alhaddad IA, Hammoudeh A, et al
    Effect of ColchiciNe on the InciDence of Atrial Fibrillation in Open Heart Surgery Patients: END-AF Trial.
    Am Heart J. 2016;178:102-7.
    PubMed     Text format     Abstract available


  17. RAO C, Du J, Li X, Li J, et al
    Rationale and design of a randomized cluster trial to improve guideline-adherence of secondary preventive drugs prescription after coronary artery bypass grafting in China: Measurement and Improvement Studies of Surgical Coronary Revascularization: Se
    Am Heart J. 2016;178:9-18.
    PubMed     Text format     Abstract available


    July 2016
  18. PEGUERO JG, Lo Presti S, Issa O, Podesta C, et al
    Simplified prediction of postoperative cardiac surgery outcomes with a novel score: R2CHADS2.
    Am Heart J. 2016;177:153-9.
    PubMed     Text format     Abstract available


  19. TING R, Tejpal A, Finken L, Fisher M, et al
    Repatriation to referral hospital after reperfusion of STEMI patients transferred for primary percutaneous coronary intervention: Insights of a Canadian regional STEMI care system.
    Am Heart J. 2016;177:145-52.
    PubMed     Text format     Abstract available


  20. ZANGRILLO A, Alvaro G, Pisano A, Guarracino F, et al
    A randomized controlled trial of levosimendan to reduce mortality in high-risk cardiac surgery patients (CHEETAH): Rationale and design.
    Am Heart J. 2016;177:66-73.
    PubMed     Text format     Abstract available


    June 2016
  21. DE LUCA L, Capranzano P, Patti G, Parodi G, et al
    Switching of platelet P2Y12 receptor inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Review of the literature and practical considerations.
    Am Heart J. 2016;176:44-52.
    PubMed     Text format     Abstract available


  22. VAN DER HEIJDEN LC, Kok MM, Danse PW, Schramm AR, et al
    Small-vessel treatment with contemporary newer-generation drug-eluting coronary stents in all-comers: Insights from 2-year DUTCH PEERS (TWENTE II) randomized trial.
    Am Heart J. 2016;176:28-35.
    PubMed     Text format     Abstract available


  23. ANDERSON LL, Dai D, Miller AL, Roe MT, et al
    Percutaneous coronary intervention for older adults who present with syncope and coronary artery disease? Insights from the National Cardiovascular Data Registry.
    Am Heart J. 2016;176:1-9.
    PubMed     Text format     Abstract available


    May 2016
  24. PARSH J, Seth M, Briguori C, Grossman P, et al
    The optimal definition of contrast-induced acute kidney injury for prediction of inpatient mortality in patients undergoing percutaneous coronary interventions.
    Am Heart J. 2016;175:160-7.
    PubMed     Text format     Abstract available


    April 2016
  25. BANOVIC M, Iung B, Bartunek J, Asanin M, et al
    Rationale and design of the Aortic Valve replAcemenT versus conservative treatment in Asymptomatic seveRe aortic stenosis (AVATAR trial): A randomized multicenter controlled event-driven trial.
    Am Heart J. 2016;174:147-53.
    PubMed     Text format     Abstract available


  26. ZIMERMAN A, Lopes RD, Stebbins AL, Guimaraes PO, et al
    Pooled analysis of adverse event collection from 4 acute coronary syndrome trials.
    Am Heart J. 2016;174:60-7.
    PubMed     Text format     Abstract available


  27. LIKOSKY DS, Zhang M, Paone G, Collins J, et al
    Impact of institutional culture on rates of transfusions during cardiovascular procedures: The Michigan experience.
    Am Heart J. 2016;174:1-6.
    PubMed     Text format     Abstract available


    March 2016
  28. UEDA H, Kido A, Matsuhisa S, Asawa K, et al
    Addition of cilostazol to aspirin therapy for secondary prevention of cardiovascular and cerebrovascular disease in patients undergoing percutaneous coronary intervention: A randomized, open-label trial.
    Am Heart J. 2016;173:134-42.
    PubMed     Text format     Abstract available


  29. LU J, Bagai A, Buller C, Cheema A, et al
    Incidence and characteristics of inappropriate and false-positive cardiac catheterization laboratory activations in a regional primary percutaneous coronary intervention program.
    Am Heart J. 2016;173:126-33.
    PubMed     Text format     Abstract available


  30. ACHARJEE S, Teo KK, Jacobs AK, Hartigan PM, et al
    Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial.
    Am Heart J. 2016;173:108-17.
    PubMed     Text format     Abstract available


  31. VAVALLE JP, van Diepen S, Clare RM, Hochman JS, et al
    Renal failure in patients with ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention: Predictors, clinical and angiographic features, and outcomes.
    Am Heart J. 2016;173:57-66.
    PubMed     Text format     Abstract available


  32. ESCARCEGA RO, Baker NC, Lipinski MJ, Koifman E, et al
    Clinical profiles and correlates of mortality in nonagenarians with severe aortic stenosis undergoing transcatheter aortic valve replacement.
    Am Heart J. 2016;173:118-25.
    PubMed     Text format     Abstract available


  33. NIJENHUIS VJ, Bennaghmouch N, Hassell M, Baan J Jr, et al
    Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve Implantation.
    Am Heart J. 2016;173:77-85.
    PubMed     Text format     Abstract available


  34. VASSALLI G, Klersy C, De Servi S, Galatius S, et al
    Can the optimal type of stent be predicted based on clinical risk factors? A subgroup analysis of the randomized BASKET-PROVE trial.
    Am Heart J. 2016;173:1-7.
    PubMed     Text format     Abstract available


    February 2016
  35. SARA JD, Lennon RJ, Gulati R, Singh M, et al
    Utility of the Framingham Risk Score in predicting secondary events in patients following percutaneous coronary intervention: A time-trend analysis.
    Am Heart J. 2016;172:115-28.
    PubMed     Text format     Abstract available


  36. LIU Y, Chen JY, Huo Y, Ge JB, et al
    Aggressive hydraTion in patients with ST-Elevation Myocardial infarction undergoing Primary percutaneous coronary intervention to prevenT contrast-induced nephropathy (ATTEMPT): Study design and protocol for the randomized, controlled trial, the ATTEM
    Am Heart J. 2016;172:88-95.
    PubMed     Text format     Abstract available


  37. DIDIER R, Gaglia MA Jr, Koifman E, Kiramijyan S, et al
    Cerebrovascular accidents after percutaneous coronary interventions from 2002 to 2014: Incidence, outcomes, and associated variables.
    Am Heart J. 2016;172:80-7.
    PubMed     Text format     Abstract available


  38. HOEKSTRA M, Hessels L, Rienstra M, Yeh L, et al
    Computer-guided normal-low versus normal-high potassium control after cardiac surgery: No impact on atrial fibrillation or atrial flutter.
    Am Heart J. 2016;172:45-52.
    PubMed     Text format     Abstract available


  39. SEBBEN JC, Pinto Ribeiro DR, Lopes RD, de Winter R, et al
    The role of diabetes mellitus in the composition of coronary thrombi in patients presenting with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Am Heart J. 2016;172:26-33.
    PubMed     Text format     Abstract available


  40. WANG TY, McCoy LA, Bhatt DL, Rao SV, et al
    Multivessel vs culprit-only percutaneous coronary intervention among patients 65 years or older with acute myocardial infarction.
    Am Heart J. 2016;172:9-18.
    PubMed     Text format     Abstract available


  41. SAIKI H, Sugimoto M, Kuwata S, Kurishima C, et al
    Novel mechanisms for cerebral blood flow regulation in patients with congenital heart disease.
    Am Heart J. 2016;172:152-9.
    PubMed     Text format     Abstract available


  42. NYTROEN K, Yardley M, Rolid K, Bjorkelund E, et al
    Design and rationale of the HITTS randomized controlled trial: Effect of High-intensity Interval Training in de novo Heart Transplant Recipients in Scandinavia.
    Am Heart J. 2016;172:96-105.
    PubMed     Text format     Abstract available


    January 2016
  43. EYUBOGLU M
    Preoperative diagnosis and postoperative prognosis in patients undergoing coronary artery bypass graft surgery.
    Am Heart J. 2016;171:e9.
    PubMed     Text format    


  44. HERTZBERG D, Sartipy U, Holzmann MJ
    Letter in response to "Assessing the association of diabetes mellitus with acute kidney injury after coronary artery bypass grafting" by Fu-Shan Xue et al.
    Am Heart J. 2016;171:e3.
    PubMed     Text format    


  45. BAINEY KR, Norris C, Shavadia J
    Response to: Letter to the Editor regarding the manuscript "Symptomatic graft failure and impact on clinical outcome after coronary artery bypass grafting surgery: Results from the Alberta Provincial Project for Outcome Assessment in Coronary Heart Di
    Am Heart J. 2016;171:e11.
    PubMed     Text format    


  46. XUE FS, Liu GP, Li RP
    Assessing the association of diabetes mellitus with acute kidney injury after coronary artery bypass grafting.
    Am Heart J. 2016;171:e1-2.
    PubMed     Text format    


  47. WARREN J, Mehran R, Baber U, Xu K, et al
    Incidence and impact of acute kidney injury in patients with acute coronary syndromes treated with coronary artery bypass grafting: Insights from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI)
    Am Heart J. 2016;171:40-7.
    PubMed     Text format     Abstract available


  48. SHAH R, Rogers KC, Matin K, Askari R, et al
    An updated comprehensive meta-analysis of bivalirudin vs heparin use in primary percutaneous coronary intervention.
    Am Heart J. 2016;171:14-24.
    PubMed     Text format     Abstract available


  49. KOLLURI R, Plessa AL, Sanders MC, Singh NK, et al
    A randomized study of the safety and efficacy of fondaparinux versus placebo in the prevention of venous thromboembolism after coronary artery bypass graft surgery.
    Am Heart J. 2016;171:1-6.
    PubMed     Text format     Abstract available


    December 2015
  50. BOYDEN TF, Joynt KE, McCoy L, Neely ML, et al
    Collaborative quality improvement vs public reporting for percutaneous coronary intervention: A comparison of percutaneous coronary intervention in New York vs Michigan.
    Am Heart J. 2015;170:1227-33.
    PubMed     Text format     Abstract available


  51. IZADI AMOLI A, Bozorgi A, HajHossein Talasaz A, Salehi Omran A, et al
    Efficacy of colchicine versus placebo for the treatment of pericardial effusion after open-heart surgery: A randomized, placebo-controlled trial.
    Am Heart J. 2015;170:1195-201.
    PubMed     Text format     Abstract available


  52. DASARI TW, Saucedo JF, Krim S, Alkhouli M, et al
    Clinical characteristics and in hospital outcomes of heart transplant recipients with allograft vasculopathy undergoing percutaneous coronary intervention: Insights from the National Cardiovascular Data Registry.
    Am Heart J. 2015;170:1086-91.
    PubMed     Text format     Abstract available


  53. KOHSAKA S, Miyata H, Ueda I, Masoudi FA, et al
    An international comparison of patients undergoing percutaneous coronary intervention: A collaborative study of the National Cardiovascular Data Registry (NCDR) and Japan Cardiovascular Database-Keio interhospital Cardiovascular Studies (JCD-KiCS).
    Am Heart J. 2015;170:1077-85.
    PubMed     Text format     Abstract available


    November 2015
  54. DUDEK D, Dziewierz A, Widimsky P, Bolognese L, et al
    Impact of prasugrel pretreatment and timing of coronary artery bypass grafting on clinical outcomes of patients with non-ST-segment elevation myocardial infarction: From the A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST-Elevation Myo
    Am Heart J. 2015;170:1025-1032.
    PubMed     Text format     Abstract available


  55. HERTZBERG D, Sartipy U, Holzmann MJ
    Type 1 and type 2 diabetes mellitus and risk of acute kidney injury after coronary artery bypass grafting.
    Am Heart J. 2015;170:895-902.
    PubMed     Text format     Abstract available


  56. COHEN MG, Matthews R, Maini B, Dixon S, et al
    Percutaneous left ventricular assist device for high-risk percutaneous coronary interventions: Real-world versus clinical trial experience.
    Am Heart J. 2015;170:872-9.
    PubMed     Text format     Abstract available


  57. CHEN WR, Hu SY, Chen YD, Zhang Y, et al
    Effects of liraglutide on left ventricular function in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Am Heart J. 2015;170:845-54.
    PubMed     Text format     Abstract available


  58. SNIPELISKY D, Stulak JM, Schettle SD, Sharma S, et al
    Psychosocial characteristics and outcomes in patients with left ventricular assist device implanted as destination therapy.
    Am Heart J. 2015;170:887-94.
    PubMed     Text format     Abstract available


    October 2015
  59. GOTZMANN M, Knoop H, Ewers A, Mugge A, et al
    Impact of lung diseases on morbidity and mortality after transcatheter aortic valve implantation: Insights from spirometry and body plethysmography.
    Am Heart J. 2015;170:837-842.
    PubMed     Text format     Abstract available


  60. SINNING JM, Wollert KC, Sedaghat A, Widera C, et al
    Risk scores and biomarkers for the prediction of 1-year outcome after transcatheter aortic valve replacement.
    Am Heart J. 2015;170:821-9.
    PubMed     Text format     Abstract available


  61. PELLATON C, Cayla G, Silvain J, Zeymer U, et al
    Incidence and consequence of major bleeding in primary percutaneous intervention for ST-elevation myocardial infarction in the era of radial access: an analysis of the international randomized Acute myocardial infarction Treated with primary angioplas
    Am Heart J. 2015;170:778-86.
    PubMed     Text format     Abstract available


  62. CLEMMENSEN P, Roe MT, Hochman JS, Cyr DD, et al
    Long-term outcomes for women versus men with unstable angina/non-ST-segment elevation myocardial infarction managed medically without revascularization: Insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage
    Am Heart J. 2015;170:695-705.
    PubMed     Text format     Abstract available


    September 2015
  63. DUPPEN N, Etnel JR, Spaans L, Takken T, et al
    Does exercise training improve cardiopulmonary fitness and daily physical activity in children and young adults with corrected tetralogy of Fallot or Fontan circulation? A randomized controlled trial.
    Am Heart J. 2015;170:606-14.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Thoracic Surgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: